I’m heading to Wisconsin w/ CNBC next week to attend Epic’s annual Users Group Meeting! 🤠🪩🎉 Looking forward to talking all things health tech, shoot me a note if you’ll be there too! (& send tips/must-sees for this first-timer) #EpicUGM

@Ro just launched a free insurance coverage checker for GLP-1s. all the details in my latest with Ashley Capoot: cnbc.com/2024/08/13/ro-…

New: @Ro launched a free new tool to help patients find out if their insurance will cover GLP-1s. It's available online starting today, and patients just need to input some basic medical/insurance information. Latest w/ Annika Kim Constantino ! cnbc.com/2024/08/13/ro-…

Big get for Abridge today, the tech is now available to Kaiser Permanente clinicians: about.kaiserpermanente.org/news/press-rel…

ICYMI yesterday: Some new developments around #TEFCA, the medical records exchange network the federal govt. is building - Epic said its goal is to have all customers live on TEFCA by end of 2025 - Carequality announced it is aligning with TEFCA cnbc.com/2024/08/16/epi…

Hello from Epic! Er.. uhh Oz? #UGM24

New: AI stole the show at Epic's Users Group Meeting this week (though Judy's swan costume was a close contender). The company shared some of the 100+ AI features it's working on, as well as a glimps into where its tech is headed. More here! #UGM24 cnbc.com/2024/08/21/epi…

Exclusive w/ Annika Kim Constantino: Another day, another new GLP-1 program! Health-care marketplace Sesame will help eligible consumers access compounded versions of Novo Nordisk’s blockbuster obesity drug Wegovy for $249 per month. 👇👇👇 cnbc.com/2024/08/21/ses…

New: Dexcom launched its first over-the-counter CGM in the U.S. on Monday. It's available without a prescription (!) and you can get a subscription for $89 a month. $DXCM I've been testing it since early August, here's what you need to know: cnbc.com/2024/08/26/dex…

New: In a galaxy far, far away from Wall Street lies the sprawling, 1,670-acre headquarters for Epic Systems. I spent time exploring the whimsical campus, which has become the stuff of legend within the health-care industry. It did not disappoint! 👇🧙‍♂️👽 cnbc.com/2024/09/01/ins…

New: Abbott launched its over-the-counter continuous glucose monitor #Lingo in the U.S., starting at $49. It's part of an emerging class of consumer-friendly biosensors that can teach users how their bodies respond to food, exercise and stress. $ABT cnbc.com/2024/09/05/-ab…

luv 2 liveblog with kif, Ashley Capoot & Todd Haselton

ICYMI: Last month, the American Red Cross declared an emergency blood shortage after its supply fell by more than 25% in July. One startup’s solution? Lab-grown blood. Meet Safi Biotherapeutics, a company working to manufacture cheap red blood cells at scale. cnbc.com/2024/09/11/saf…

The FDA has authorized Apple's OTC hearing aid software for AirPods Pro cnbc.com/2024/09/12/app…

Exclusive: Another GLP-1 program hit the market today. Noom is helping patients access compounded semaglutide through a new offering that starts at $149. It can also support users if they decide they want to taper off the medication. More details! cnbc.com/2024/09/12/noo…

New: The FDA approved Apple's sleep apnea detection feature this morning. Here's how it works for Apple Watch users. $AAPL cnbc.com/2024/09/16/fda…

It's that time of year again! I'll be at HLTH with CNBC next month. Shoot me a note if you'll be there too, would love to connect 🤠🥳 #HLTHUSA #HLTH24

ICYMI last night: All the independent directors of 23andMe resigned from the board Tuesday, a move that CEO Anne Wojcicki said left her “surprised and disappointed.” She told employees she is still committed to taking the company private. Read the memo: cnbc.com/2024/09/17/23a…